Matches in Nanopublications for { ?s ?p "[To investigate the contribution of PALB2 mutations to Chinese non-BRCA1/BRCA2 hereditary breast cancer, we screened all coding exons and intron-exon boundaries of PALB2 in 360 Chinese women with early-onset breast cancer or affected relatives from five breast disease clinical centers in China by utilizing PCR-DHPLC and DNA sequencing analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP229894.RAR7VWfERpd4e8rrmCATMJlg1IeoZZPt0Vcf_Q6l8TsQk130_assertion description "[To investigate the contribution of PALB2 mutations to Chinese non-BRCA1/BRCA2 hereditary breast cancer, we screened all coding exons and intron-exon boundaries of PALB2 in 360 Chinese women with early-onset breast cancer or affected relatives from five breast disease clinical centers in China by utilizing PCR-DHPLC and DNA sequencing analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP229894.RAR7VWfERpd4e8rrmCATMJlg1IeoZZPt0Vcf_Q6l8TsQk130_provenance.
- NP902623.RAFF0huviRSFshVdaX9BPZ8No6CnrmaHP77AKSsdS1yy8130_assertion description "[To investigate the contribution of PALB2 mutations to Chinese non-BRCA1/BRCA2 hereditary breast cancer, we screened all coding exons and intron-exon boundaries of PALB2 in 360 Chinese women with early-onset breast cancer or affected relatives from five breast disease clinical centers in China by utilizing PCR-DHPLC and DNA sequencing analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP902623.RAFF0huviRSFshVdaX9BPZ8No6CnrmaHP77AKSsdS1yy8130_provenance.
- assertion description "[To investigate the contribution of PALB2 mutations to Chinese non-BRCA1/BRCA2 hereditary breast cancer, we screened all coding exons and intron-exon boundaries of PALB2 in 360 Chinese women with early-onset breast cancer or affected relatives from five breast disease clinical centers in China by utilizing PCR-DHPLC and DNA sequencing analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP668589.RAQJvgYSey_EaMIO7Zckyy607SHFoKEwjZn5Q6c49X8Nk130_assertion description "[To investigate the contribution of PALB2 mutations to Chinese non-BRCA1/BRCA2 hereditary breast cancer, we screened all coding exons and intron-exon boundaries of PALB2 in 360 Chinese women with early-onset breast cancer or affected relatives from five breast disease clinical centers in China by utilizing PCR-DHPLC and DNA sequencing analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668589.RAQJvgYSey_EaMIO7Zckyy607SHFoKEwjZn5Q6c49X8Nk130_provenance.
- NP668591.RAaIOMGJ-6-DL9gDajXYjtH62Hr-8ToxF4AApz9XDyex8130_assertion description "[To investigate the contribution of PALB2 mutations to Chinese non-BRCA1/BRCA2 hereditary breast cancer, we screened all coding exons and intron-exon boundaries of PALB2 in 360 Chinese women with early-onset breast cancer or affected relatives from five breast disease clinical centers in China by utilizing PCR-DHPLC and DNA sequencing analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP668591.RAaIOMGJ-6-DL9gDajXYjtH62Hr-8ToxF4AApz9XDyex8130_provenance.
- NP945338.RAFIQeJiF0HDA-7c1-SrHBsODy_Bx7KoWzXZhyKq0VnXA130_assertion description "[To investigate the contribution of PALB2 mutations to Chinese non-BRCA1/BRCA2 hereditary breast cancer, we screened all coding exons and intron-exon boundaries of PALB2 in 360 Chinese women with early-onset breast cancer or affected relatives from five breast disease clinical centers in China by utilizing PCR-DHPLC and DNA sequencing analysis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP945338.RAFIQeJiF0HDA-7c1-SrHBsODy_Bx7KoWzXZhyKq0VnXA130_provenance.